Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |